The federal government’s proposed Agile Licensing drug approval regulations mean Canada will have less information about the risks of new medicines, and higher costs.
- Professor of Economics, University of Calgary
The development of resistant bacteria over the past 50 years stands testament to the power of evolution. While scientists have discovered or created hundreds of antibiotics to kill bacteria, those bacteria…
Contact Aidan for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Website
- Article Feed
- ORCID
- Joined
